Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting
Introduction and Aims: To project the long-term cost-effectiveness of treating non-valvular atrial fibrillation (AF) patients for stroke prevention with rivaroxaban compared to warfarin in Portugal. Methods: A Markov model was used that included health and treatment states describing the management...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-09-01
|
Series: | Revista Portuguesa de Cardiologia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S087025511400184X |